Study of AOBO-001 for Overactive Bladder With Urge Urinary Incontinence and Frequency

NCT01294982 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: AOBO-001
DRUG: AOBO-001
DRUG: Placebo

Sponsor

American Oriental Bioengineering, Inc.